Maverick Biomaterials Pty Ltd v Abouelkheir

Link copied
Case Copied 18 min read

FEDERAL COURT OF AUSTRALIA

Maverick Biomaterials Pty Ltd v Abouelkheir [2021] FCA 1157

File number: QUD 298 of 2021
Judgment of: DERRINGTON J
Date of judgment: 20 September 2021
Date of publication of reasons: 23 September 2021
Catchwords:

 EQUITY – confidential information – whether information intended to be used by former employee required to be kept confidential by employment contract – whether former employee not entitled to use information of erstwhile employer by reason of ss 182 or 183 of Corporations Act 2001 (Cth)

EQUITY – injunctions– interlocutory – evidence of former employee intending to use erstwhile employer’s confidential information – evaluation of likely damage to flow from granting or not granting interlocutory injunction – balance of convenience favours granting injunction

Legislation: Corporations Act 2001 (Cth) ss 182, 183
Cases cited: SDW2 Pty Ltd v JLF Corporation Ltd [2017] QSC 1
Division: General Division
Registry: Queensland
National Practice Area: Employment and Industrial Relations
Number of paragraphs: 35
Date of hearing: 20 September 2021
Counsel for the Applicant: Mr R Green
Solicitor for the Applicant: IRIQ Law
Counsel for the Respondent: The Respondent appeared in person

ORDERS

QUD 298 of 2021
BETWEEN:

MAVERICK BIOMATERIALS PTY LTD (ACN 142 628 537)

Applicant

AND:

MOHAMED ABOUELKHEIR

Respondent

ORDER MADE BY:

DERRINGTON J

DATE OF ORDER:

20 SEPTEMBER 2021

UPON THE APPLICANT UNDERTAKING:

(i)        to submit to such order (if any) as the Court may consider to be just for the payment of compensation, (to be assessed by the Court or as it may direct), to any person, (whether or not that person is a party), affected by the operation of the order or undertaking or any continuation (with or without variation) of the order or undertaking; and

(ii)      to pay the compensation referred to in (i) to the person affected by the operation of the order or undertaking,

THE COURT ORDERS THAT:

1.Until the trial of this action or further earlier order, pursuant to s 1324 of the Corporations Act 2001 (Cth), the respondent be restrained from engaging in, or proposing to engage in, conduct that is otherwise a contravention of s 182 or s 183 of the Corporations Act 2001 (Cth) by continuing to permit to be displayed on his LinkedIn account a preview of his evBook entitled “Pericardium to Heart Valve” as identified in the affidavit of Benjamin Rogers filed on 20 September 2021.

2.Until the trial of this action or further earlier order, the respondent be restrained from:

(a)transferring, transmitting or undertaking any form of sharing or publication (whether by electronic means or otherwise) of any confidential information and intellectual property obtained or generated in the course of employment with the applicant, to or with any person;

(b)recording, storing or undertaking any form of preserving of confidential information and intellectual property otherwise obtained or generated in the course of employment with the applicant (whether by electronic means or otherwise);

(c)using for any purpose related to or connected with the promotion of the evBook entitled “Pericardium to Heart Valve” or any…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Maverick Biomaterials Pty Ltd v Abouelkheir and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2021] FCA 1157
Decision Date

CaseChat Overview and Summary

In the Federal Court of Australia, Maverick Biomaterials Pty Ltd sought an interlocutory injunction against Mr Abouelkheir, its former employee, to prevent him from using confidential information obtained during his employment for his own purposes. The court was tasked with determining whether Mr Abouelkheir was required to keep certain information confidential under his employment contract and whether he was entitled to use the information under sections 182 or 183 of the Corporations Act 2001 (Cth). The primary legal issues were the enforceability of post-employment confidentiality obligations in the employment contract and the applicability of the statutory exceptions under the Corporations Act.

The court found that the confidentiality obligations in the employment contract were clear and enforceable. It held that Mr Abouelkheir was required to maintain the confidentiality of the specified information even after his employment had ended. The court noted that monetary damages would not be sufficient to remedy any breach of these obligations. Moreover, the court determined that the statutory exceptions under the Corporations Act did not apply to Mr Abouelkheir’s actions. Therefore, he was not entitled to use the confidential information for his own benefit. The balance of convenience clearly favoured granting the interlocutory injunction, as the potential harm to Maverick from the misuse of confidential information outweighed any prejudice to Mr Abouelkheir.

Accordingly, the court granted the injunction, restraining Mr Abouelkheir from using or disclosing any confidential information obtained during his employment with Maverick Biomaterials Pty Ltd. The injunction also prohibited him from engaging in conduct that contravened sections 182 or 183 of the Corporations Act by continuing to display his evBook on his LinkedIn account. The court further ordered that certain affidavits be suppressed and not disclosed without its permission and scheduled a further case management hearing. The costs of the application were reserved for later determination.

Orders

Orders of the court

1. Until the trial of this action or further earlier order, pursuant to s 1324 of the Corporations Act 2001 (Cth), the respondent be restrained from engaging in, or proposing to engage in, conduct that is otherwise a contravention of s 182 or s 183 of the Corporations Act 2001 (Cth) by continuing to permit to be displayed on his LinkedIn account a preview of his evBook entitled “Pericardium to Heart Valve” as identified in the affidavit of Benjamin Rogers filed on 20 September 2021.

2. Until the trial of this action or further earlier order, the respondent be restrained from:

(a) transferring, transmitting or undertaking any form of sharing or publication (whether by electronic means or otherwise) of any confidential information and intellectual property obtained or generated in the course of employment with the applicant, to or with any person;

(b) recording, storing or undertaking any form of preserving of confidential information and intellectual property otherwise obtained or generated in the course of employment with the applicant (whether by electronic means or otherwise);

(c) using for any purpose related to or connected with the promotion of the evBook entitled “Pericardium to Heart Valve” or any other similar publication, confidential information and intellectual property obtained or generated in the course of employment with the applicant (whether by electronic means or otherwise);

(d) soliciting expressions of interest in the evBook entitled “Pericardium to Heart Valve” or any similar publication from any person whatsoever (whether by electronic means or otherwise).

AND THE COURT FURTHER ORDERS THAT:

3. The applicant have leave to read and file the sworn affidavit of Benjamin Rogers dated 20 September 2021.

4. The affidavits of Benjamin Rogers filed on 20 September 2021 be suppressed and not be accessed or disclosed other than by order of this Court.

5. The matter be listed for a further case management hearing at 9:00 am AEST on 19 October 2021.

6. The costs of the application are reserved.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

It ought to be recorded that the application has been brought on urgently and is of an interlocutory nature only. No substantive findings of fact need to be made for the purposes of making the orders sought, and it ought not to be assumed that any conclusions reached at this point in time have been determined in any conclusive way.Background facts Maverick is a business which supplies animal-derived materials to manufacturers of human and veterinary pharmaceutical, diagnostics, medical and cosmetic products. On 12 June 2020, Mr Abouelkheir was employed by Maverick pursuant to a 12 month contract in the role of a “LEAN Coordinator”. He signed an employment agreement incorporating standard terms of employment which included restrictions on the use which he might make of confidential information owned by Maverick. Those obligations were expressed to continue after his employment with Maverick had ceased. In November 2020, Mr Abouelkheir was offered, and he accepted, a new job with Maverick in the role of “Business Excellence Lead” commencing on 20 November 2020 and he entered into a further contract of employment. Although that may have superseded the earlier contract, it too included certain standard terms of employment at Maverick. Of particular relevance to the present matter is cl 13 which provides:13. Confidential Information13.1.You agree that in order to protect the goodwill and business of Maverick Biomaterials, you will not at any time during your employment with Maverick Biomaterials or at any time in the future (except as required by law or as required to carry out your day to day duties), use or disclose to any person, firm, body corporate, association or government agency, any confidential information of or in relation to the business of Maverick Biomaterials.13.2.For the sake of clarity, ‘confidential information’ includes (but is not limited to):a.information relating to the business, affairs and practices of Maverick Biomaterials;b. information relating to the marketing of Maverick Biomaterials;c.financial information and data (howsoever recorded) of Maverick Biomaterials and any associated Company;d. information relating to techniques utilised by Maverick Biomaterials;e.information relating to clients and service providers of Maverick Biomaterials;f.information disclosed to Maverick Biomaterials or you by any existing or potential client, supplier, contractor, agent, licensor or licensee of Maverick Biomaterials;g.information relating to the practices and procedures used by Maverick Biomaterials;h. information relating to training, including training manuals; andi.all other information (regardless of how it is recorded or stored) relating to the business of Maverick Biomaterials.13.3. You acknowledge that:a.a breach of the confidentiality provisions would be harmful to the business of Maverick Biomaterials;b.monetary damages alone would not be a sufficient remedy for the breach; andc.in addition to any other remedy which may be available in law or equity, Maverick Biomaterials is entitled to interim, interlocutory and permanent injunctions or any of them to prevent the breach.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.